Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care
- 6 August 2003
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 17 (5) , 753-781
- https://doi.org/10.1016/s1521-6942(03)00077-9
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trialArthritis & Rheumatism, 2003
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Biannual Radiographic Assessments of Hands and Feet in a Three‐Year Prospective Followup of Patients with Early Rheumatoid ArthritisArthritis & Rheumatism, 1992
- The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty‐five years of diseaseArthritis & Rheumatism, 1991
- Bias in Treatment Assignment in Controlled Clinical TrialsNew England Journal of Medicine, 1983
- The Competing Objectives of Randomized TrialsNew England Journal of Medicine, 1980
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980
- Controversy in Counting and Attributing Events in Clinical TrialsNew England Journal of Medicine, 1979
- Studies of Illness in the AgedJAMA, 1963